Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.746443
Title: Molecular and functional characterisation of linear ubiquitination in the liver
Author: Shimizu, Y.
ISNI:       0000 0004 7223 755X
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2017
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Linear ubiquitination is one of the key post-translational modifications that regulate immune signalling pathways and cell death. The only known enzyme complex capable of forming linear ubiquitin chains de novo is the linear ubiquitin chain assembly complex (LUBAC), and its catalytic core component is HOIP. To understand the underlying mechanisms of liver inflammation and associated carcinogenesis, the physiological role of LUBAC in the liver parenchyma was investigated. Here I report that HOIP deficiency in liver parenchymal cells triggered spontaneous cell death and inflammation in murine livers at early stages and tumourigenesis later in life. HOIP-deficient livers displayed increased cell death, including apoptosis, regeneration and immune cell infiltration. TNF-induced NF-κB activation was attenuated in HOIP-deficient primary hepatocytes and they were more susceptible to TNF-induced cell death independently of their impaired gene- activatory capacity. Unexpectedly, however, liver damage observed in HOIPdeficient livers was TNFR1-independent as co-deletion of TNFR1 did not ameliorate cell death in HOIP-deficient livers whilst mitigating their inflammation. In accordance with increased cell death, HOIP-deficient hepatocytes displayed enhanced formation of a death-inducing signalling complex containing FADD, RIPK1, caspase-8 and c-FLIP. This elevated signalling complex formation in HOIP-deficient hepatocytes was independent of lowered gene-activatory capacity and the presence of TNFR1. Moreover, combined ablation of systemic caspase-8 and MLKL completely prevented liver damage due to loss of HOIP, whereas MLKL deficiency did not have a beneficial effect. This demonstrates a crucial role for aberrant cell death in HOIPdeficient livers. Collectively, these results identify LUBAC as a previously unrecognised tumour suppressor, which acts by restraining TNFR1-independent FADD-RIPK1-caspase-8 complex formation and caspase-8-dependent apoptosis, regardless of its gene-regulatory function, in hepatocytes to prevent liver damage and inflammation.
Supervisor: Walczak, H. Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.746443  DOI: Not available
Share: